The Biologic Therapy Access Working Group is a network of policy-minded clinicians who prescribe biological products and advocate for patient-centered care. By participating in advocacy initiatives and the development of educational resources, working group members ensure that the clinician’s perspective informs policy discussions on biologics and biosimilars.
To learn more, or to join AfPA’s Biologic Therapy Access Working Group, please email Isabelle Logsdon at [email protected].
Learn more about the role biologics and biosimilars play in treating chronic diseases.
